DHR

Key Insights into Danaher Stock Performance

Shares of Industrials sector company Danaher moved -1.8% today, and are now trading at a price of $263.08. The Large-Cap stock's daily volume was 3,626,851 compared to its average volume of 2,702,957. The S&P 500 index returned a -0.0% performance.

Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The company is based in Washington and has 61,000 full time employees. Its market capitalization is $194,859,925,504. Danaher currently offers its equity investors a dividend that yields 0.4% per year.

20 analysts are following Danaher and have set target prices ranging from $220.0 to $297.0 per share. On average, they have given the company a rating of buy. At today's prices, DHR is trading -3.31% away from its average analyst target price of $272.09 per share.

Over the last year, DHR's share price has increased by 24.7%, which represents a difference of 1.4% when compared to the S&P 500. The stock's 52 week high is $269.11 per share whereas its 52 week low is $182.09. With average free cash flows of $5.41 Billion that have been growing at an average rate of 11.4% over the last 5 years, Danaher is in a position to continue its strong stock performance trend.

Date Reported Cash Flow from Operations ($ k) Capital expenditures ($ k) Free Cash Flow ($ k) YoY Growth (%)
2023 7,164,000 1,383,000 5,781,000 -21.89
2022 8,519,000 1,118,000 7,401,000 3.98
2021 8,358,000 1,240,000 7,118,000 31.4
2020 6,208,000 791,000 5,417,000 63.36
2019 3,952,000 636,000 3,316,000 -3.55
2018 4,022,000 584,000 3,438,000
The above analysis is intended for educational purposes only and was performed on the basis of publicly available data. It is not to be construed as a recommendation to buy or sell any security. Any buy, sell, or other recommendations mentioned in the article are direct quotations of consensus recommendations from the analysts covering the stock, and do not represent the opinions of Market Inference or its writers. Past performance, accounting data, and inferences about market position and corporate valuation are not reliable indicators of future price movements. Market Inference does not provide financial advice. Investors should conduct their own review and analysis of any company of interest before making an investment decision.

IN FOCUS